Sort
8,912 grants matching “sars cov 2”
Mechanisms and Duration of Immunity to SARS-CoV-2
$440,000Scott Dexter Boyd · Stanford University · U54 · FY2022 · CA
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2
$440,000Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2022 · CA
Microglia mediate cognitive dysfunction in elderly survivors of pneumonia
$440,000Alexander Misharin · Northwestern University At Chicago · R21 · FY2022 · AG
CRISPR screens for SARS-CoV-2 Host Factors
$440,000John Gerard Doench · Broad Institute, Inc. · R21 · FY2020 · AI
Admin-Core-001
$439,872James E Robinson · Tulane University Of Louisiana · U54 · FY2022 · CA
Tulane University COVID Antibody and Immunity Network (TUCAIN)
$439,872James E Robinson · Tulane University Of Louisiana · U54 · FY2022 · CA
Neurological consequences of COVID-19 during the early recovery period: Imaging Analysis of the Blood Brain Barrier and Neurovascular alterations
$439,694Ann B Ragin · Northwestern University At Chicago · R21 · FY2021 · NS
Structural and functional analysis of the coronavirus spike protein fusion peptide
$439,686Gary R Whittaker · Cornell University · R01 · FY2021 · AI
Admin-Core-001
$439,659Eugene M. Oltz · Ohio State University · U54 · FY2022 · CA
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)
$439,659Eugene M. Oltz · Ohio State University · U54 · FY2022 · CA
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events
$439,554Robert Yeh · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
CoVPN 3001 - A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults.
$439,437Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Project 1: Serology
$439,325Taia Wang · Stanford University · U54 · FY2022 · CA
CNS-mediated fever after Adolescent Intermittent Ethanol
$439,282Terrence Deak · State University Of Ny,Binghamton · R01 · FY2023 · AA
Observation and quantification of respiratory droplets by laser light scattering
$439,141Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Observation and quantification of respiratory droplets by laser light scattering
$439,141Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Defining the Translocation Mechanisms of SARS-CoV-2 nsp13 Helicase to Aid in Antiviral Development
$439,024Martin McCullagh · Oklahoma State University Stillwater · R01 · FY2024 · AI
Defining the Translocation Mechanisms of SARS-CoV-2 nsp13 Helicase to Aid in Antiviral Development
$439,004Martin McCullagh · Oklahoma State University Stillwater · R01 · FY2023 · AI
Formation of a Novel SARS-CoV-2 Nucleocapsid Dimer: Impacts on Viral and Cellular Processes
$438,983Emily A. Bruce · University Of Vermont & St Agric College · R21 · FY2025 · AI
Multiplex Hybridization Colorimetric Sensor for Wild Type and Variant RNA Biomarkers
$438,878Sadagopan Krishnan · Oklahoma State University Stillwater · R15 · FY2023 · EB
Foldamers: Novel Ligands for Diverse Protein Surfaces
$438,544Yale University · R01 · FY2005 · GM
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
$438,490Shruti H Mehta · Johns Hopkins University · T32 · FY2023 · AI
SARS-CoV-2 Studies
$438,205Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$438,043Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Innate Determinants of Microbial Immunity
$438,043Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI